SCHEMBL7784246

SCHEMBL7784246

CCCC(=S)CCC(CCCCC(=O)OC)C(C)=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 3/20 0.40
BIRC2 Q13490 1/20 0.38
PPARG P37231 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
SLC1A1 P43005 1/20 0.35
PPARA Q07869 1/20 0.34
EPHX2 P34913 1/20 0.34
PABPC1 P11940 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
POLB P06746 1/20 0.33
POLA1 P09884 1/20 0.33
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793674 0.88 L3MBTL1 (0.40) L3MBTL1TSHRBIRC2PPARGCA1
SCHEMBL7794217 0.82 TSHR (0.42) L3MBTL1TSHRPPARGALDH1A1LMNA
SCHEMBL11587569 0.80 BIRC2 (0.49) L3MBTL1TSHRBIRC2PPARGCA1
SCHEMBL7793709 0.79 L3MBTL1 (0.40) L3MBTL1TSHRBIRC2PPARGCA1
SCHEMBL10900049 0.78 L3MBTL1 (0.50) L3MBTL1TSHRBIRC2PPARGCA1
SCHEMBL11616026 0.77 L3MBTL1 (0.54) L3MBTL1BIRC2PPARGLMNAPPARA
SCHEMBL8104568 0.76 TSHR (0.47) L3MBTL1TSHRBIRC2PPARGALDH1A1
SCHEMBL11069370 0.76 SLC1A1 (0.47) L3MBTL1TSHRBIRC2CA1CA2
SCHEMBL7784250 0.74 LMNA (0.51) TSHRALDH1A1LMNA
SCHEMBL7792778 0.74 CTSK (0.32) TSHRLMNAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947503-B1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours GALDERMA RES & DEV (FR) 2001-11-21 EP claimed
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed